The Prognostic Significance of Minimal Residual Disease in Multiple Myeloma in the Molecular Genetic Groups Msmart 3.0

被引：0
|
作者：
Garifullin, Andrey
Voloshin, Sergei
Linnikov, Sergey
Martynkevich, Irina
Kuvshinov, Alexey
Kuzyaeva, Anastasiya
Chubukina, Zhanna
Shuvaev, Vasily
Kleina, Elizaveta
Bakai, Marina
Hmidt, Alexander S.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-139239
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Minimal residual disease in multiple myeloma: current status
    Hong Ding
    Juan Xu
    Zhimei Lin
    Jingcao Huang
    Fangfang Wang
    Yan Yang
    Yushan Cui
    Hongmei Luo
    Yuhan Gao
    Xinyu Zhai
    Weicui Pang
    Li Zhang
    Yuhuan Zheng
    Biomarker Research, 9
  • [32] Role of minimal residual disease assessment in multiple myeloma
    Szalat, Raphael E.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    HAEMATOLOGICA, 2024, 109 (07) : 2049 - 2059
  • [33] Role of minimal residual disease assessment in multiple myeloma
    Szalat, Raphael E.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2049 - 2059
  • [34] Minimal residual disease diagnostics in patients with multiple myeloma
    Huhn, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 128 - 128
  • [35] Drug resistance and minimal residual disease in multiple myeloma
    Gozzetti, Alessandro
    Ciofini, Sara
    Sicuranza, Anna
    Pacelli, Paola
    Raspadori, Donatella
    Cencini, Emanuele
    Tocci, Dania
    Bocchia, Monica
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 171 - 183
  • [36] Recommendations for quantitation of minimal residual disease in multiple myeloma
    Rasmussen, T
    Johnsen, HE
    BONE MARROW TRANSPLANTATION, 2002, 29 : S128 - S128
  • [37] The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements
    Cedena, Maria-Teresa
    Martin-Clavero, Estela
    Wong, Sandy
    Shah, Nina
    Bahri, Natasha
    Alonso, Rafael
    Barcenas, Carmen
    Valeri, Antonio
    Tabares, Johny Salazar
    Sanchez-Pina, Jose
    Cuellar, Clara
    Martin, Thomas
    Wolf, Jeffrey
    Lahuerta, Juan-Jose
    Martinez-Lopez, Joaquin
    PLOS ONE, 2020, 15 (08):
  • [38] Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
    Perrot, Aurore
    Lauwers-Cances, Valerie
    Corre, Jill
    Robillard, Nelly
    Hulin, Cyrille
    Chretien, Marie-Lorraine
    Dejoie, Thomas
    Maheo, Sabrina
    Stoppa, Anne-Marie
    Pegourie, Brigitte
    Karlin, Lionel
    Garderet, Laurent
    Arnulf, Bertrand
    Doyen, Chantal
    Meuleman, Nathalie
    Royer, Bruno
    Eveillard, Jean-Richard
    Benboubker, Lotfi
    Dib, Mamoun
    Decaux, Olivier
    Jaccard, Arnaud
    Belhadj, Karim
    Brechignac, Sabine
    Kolb, Brigitte
    Fohrer, Cecile
    Mohty, Mohamad
    Macro, Margaret
    Richardson, Paul G.
    Carlton, Victoria
    Moorhead, Martin
    Willis, Tom
    Faham, Malek
    Anderson, Kenneth C.
    Harousseau, Jean-Luc
    Leleu, Xavier
    Facon, Thierry
    Moreau, Philippe
    Attal, Michel
    Avet-Loiseau, Herve
    Munshi, Nikhil
    BLOOD, 2018, 132 (23) : 2456 - 2464
  • [39] PROGNOSTIC VALUE OF SEQUENCING-BASED MINIMAL RESIDUAL DISEASE DETECTION IN PATIENTS WITH MULTIPLE MYELOMA
    Sanchez-Vega Carrion, B.
    Ruiz, Y.
    Barrios, S.
    Maldonado, R.
    Marin, C.
    Rapado, I
    Ayala, R.
    Cedena, T.
    Paiva, B.
    Garcia-Sanz, R.
    Jimenez, C.
    Mateos, M., V
    Rosinol, L.
    Blade, J.
    San Miguel, J.
    Lahuerta, J. J.
    Martinez, L. J.
    HAEMATOLOGICA, 2015, 100 : 60 - 60
  • [40] Prognostic value of deep sequencing method for minimal residual disease (MRD) detection in multiple myeloma
    Martinez-Lopez, Joaquin
    Garcia-Sanz, Ramon
    Pepin, Francois
    Ayala, Rosa
    Angeles Montalban, Maria
    Paiva, Bruno
    Weng, Li
    Barrio, Santiago
    Montejano, Laura
    Rapado, Immaculada
    Martinez, Rafael
    Jesus Blachard, Maria
    Sanchez-Godoy, Pedro
    Blade, Joan
    San-Miguel, Jesus F.
    Faham, Malek
    Jose Lahuerta, Juan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345